echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Double antibody therapy is effective against new coronavirus mutant strains

    Double antibody therapy is effective against new coronavirus mutant strains

    • Last Update: 2021-07-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Science and Technology Daily, Beijing, June 22 (Reporter Liu Xia ) Add new members to the "Arsenal" of the new crown virus! American scientists wrote in the "Nature" magazine published on the 21st that their experiments on mice and hamsters showed that the combination therapy composed of two antibodies "strongly work together" is effective against a variety of (but not all) new coronavirus mutations.


    Liu Xia

    Antibody therapy is usually used to treat hospitalized patients and critically ill patients with new crowns, but with the emergence of mutated new strains one after another, whether antibody therapy is effective against new strains has become an urgent question to be answered


    In the latest study, scientists at the University of Washington School of Medicine tested on mice and hamsters infected with a mutant strain of the new coronavirus, which have been approved by the U.


    The tested variant strains include the Alpha strain first found in the UK, the first beta strain found in South Africa, the first Gamma strain found in Brazil, and new variants similar to the Delta variant strain first found in India.


    The researchers evaluated these antibodies and antibody combinations in mice and hamsters


    The results of the study show that the anti-coronavirus drugs made of two antibodies, even if one of the antibodies has lost part or all of the ability to neutralize the mutant strain, the combined antibody (even if the dose is relatively low) can maintain the treatment of the mutant strain.


    The lead author of the research paper, Dr.


    Focus on the new crown pneumonia epidemic
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.